-
- Posted Monday March 5, 2012
TGen research scientists detail the potential of 'Personalized Medicine'
Drs. Demeure and Taverna appear March 8 on AZ SciTech Festival
forum
TEMPE, Ariz. - March 5, 2012 - Two research scientists from the
Translational Genomics Research Institute (TGen) will discuss the
potential of 'Personalize Medicine' at a forum organized as part of
the Arizona SciTech Festival.
The free public forum, presented by public radio station KJZZ
(91.5 FM) and Rio Salado College, is scheduled from 7-9 p.m. March
8 at the Rio Salado Conference Center, 2323 W. 14th Street,
Tempe.
Space is limited. Please contact Claire Kerrigan at (480) 774-8444
or [email protected] to reserve your seat.
Dr. Michael Demeure, M.D., a surgeon and Director of TGen's Rare
Cancer Unit, and Dr. Darin Taverna, Ph.D., a TGen Bioinformatician,
are among a panel of experts that also will include Barry Broome,
President and CEO of the Greater Phoenix Economic Council.
They will discuss the importance of using genetic information to
help produce medical treatments uniquely designed for each
individual patient. This approach, based on an analysis of each
patient's DNA, helps ensure they receive the right treatment in the
right dose at the right time to improve survival and enhance
quality of life.
The conversation will focus on the latest developments in custom
treatments, followed by an examination of how this new medical
model can affect patient wellness and the Valley's health and
science-related industries.
Mark Moran, KJZZ's Associate General Manager of News and Editorial
Strategy, will serve as the forum moderator.
The public can help focus the dialogue by sending comments and
questions in advance to KJZZ Public Insight Journalist, Nick
Blumberg, at (480) 774-8231 or [email protected]
Desserts and coffee will be available beginning at 6:30 p.m.
This KJZZ and Rio Salado College Personalized Medicine forum is
one of more than 200 statewide events during February and March as
part of the Arizona SciTech Festival (azscitechfest.org/).
In-kind production support is made possible in part by the Arizona
Science Center.
